Core Points - The company plans to distribute a cash dividend of 0.08 yuan per share (including tax) to all shareholders, amounting to a total of 8,035,896 yuan (including tax) based on the total share capital of 100,448,700 shares as of June 30, 2025 [1][2] - The profit distribution plan is authorized within the scope of the 2024 annual shareholders' meeting resolution and does not require further approval from the shareholders' meeting [2] - The company will no longer have a supervisory board, with the audit committee of the board of directors assuming the responsibilities previously held by the supervisory board, in accordance with the latest amendments to the Company Law and relevant regulations [4][5] Company Overview - The company is identified as倍加洁集团股份有限公司, with the stock code 603059 [4] - The company has undergone changes in its governance structure, specifically the removal of the supervisory board [4] Financial Data - The total cash dividend proposed is based on the company's total share capital as of June 30, 2025, which is 100,448,700 shares [1] - The cash dividend distribution is set to occur without any capital reserve conversion or issuance of bonus shares [1]

Group 1 - The company has revised its articles of association, which will be submitted for approval at the 2025 first extraordinary shareholders' meeting [1][3] - The revised internal control systems include rules for shareholder meetings, board meetings, independent director work, and related party transactions, among others, which also require approval at the upcoming shareholders' meeting [3][4] - The company will hold its 2025 first extraordinary shareholders' meeting on September 18, 2025, with both on-site and online voting options available [6][8] Group 2 - The meeting will be convened by the company's board of directors and is compliant with relevant laws and regulations [7] - Shareholders must register to attend the meeting, with specific requirements for natural and legal persons outlined [11][14] - Voting will occur through the Shenzhen Stock Exchange trading system and an internet voting system, with detailed procedures provided for shareholders [20][26]

Core Viewpoint - The company is focused on cost reduction and efficiency improvement, aiming for a 7.61% year-on-year decrease in total sales, management, and financial expenses by the first half of 2025 [1] Group 1 - The company is actively working on enhancing its governance system through continuous optimization of its operational management and governance structure [1] - The efforts are aimed at ensuring stability in operations and continuous improvement in operational quality [1]

第一节 重要提示 1.4公司全体董事出席董事会会议。 1.5本半年度报告未经审计。 1.6董事会决议通过的本报告期利润分配预案或公积金转增股本预案 登录新浪财经APP 搜索【信披】查看更多考评等级 公司代码：688182 公司简称：灿勤科技 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到上海证券交易所（http://www.sse.com.cn）网站仔细阅读半年度报告全文。 1.2重大风险提示 公司已在本报告中描述公司面临的风险，敬请查阅本报告"第三节 管理层讨论与分析" "四、风险因 素"相关内容，请投资者予以关注。 1.3本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司股票简况 ■ 公司存托凭证简况 □适用 √不适用 联系人和联系方式 ■ □适用 √不适用 1.7是否存在公司治理特殊安排等重要事项 □适用 √不适用 第二节 公司基本情况 2.1公司简介 2.2主要财务数据 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 ...

Core Points - The company has announced changes to its registered address, the cancellation of its supervisory board, and amendments to its articles of association [4][5][6] - The board of directors has confirmed the accuracy and completeness of the announcement, ensuring no misleading statements or omissions [4][6] - The company will no longer have a supervisory board, with the audit committee taking over its responsibilities in accordance with the revised Company Law and relevant regulations [5][6] Group 1: Company Changes - The registered address will be changed from "Building A, 22nd Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" to "Unit 2202-2, 19th Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" [4] - The supervisory board will be abolished, and its functions will be assumed by the audit committee, in line with the latest legal requirements [5][6] - The articles of association will be systematically revised to improve the governance structure, including the removal of references to the supervisory board and its members [6][7] Group 2: Governance and Compliance - The company will ensure compliance with the revised Company Law and the Shanghai Stock Exchange's listing rules [5][6] - The board has expressed gratitude to the outgoing supervisory board members for their contributions during their tenure [6] - The management is authorized to handle the necessary business registration changes and document signing related to these amendments [7]

Group 1 - Company will participate in the 2025 semi-annual performance briefing for the innovative drug industry on September 16, 2025, from 15:00 to 17:00 [2][3][4] - Investors can submit questions for the briefing from September 9 to September 15, 2025, through the Shanghai Stock Exchange Roadshow Center website or via the company's email [2][4] - The briefing will be conducted in an online text interaction format, allowing investors to engage with the company [2][3] Group 2 - The company will hold its first extraordinary general meeting of 2025 on September 15, 2025, at 10:00 AM, with both on-site and online voting options available [8][9] - The meeting will discuss various resolutions, including the approval of the 2025 semi-annual report and the special resolution regarding the cancellation of the supervisory board [11][12][33] - The company emphasizes the importance of shareholder participation and has set up a reminder service to ensure small and medium investors are informed about the meeting [20] Group 3 - The company reported significant progress in its drug development pipeline, focusing on innovative small molecule anti-cancer drugs [37][38] - Key candidates such as SY-707 and SY-5007 have reached important milestones, with SY-5007 preparing for a new drug application submission [39][40] - The company is also expanding its research and development capabilities by establishing a new drug research and industrialization base with an investment of up to 787 million yuan [44][45] Group 4 - The company has maintained a strong financial position, with total assets of 819.45 million yuan and no interest-bearing liabilities as of mid-2025 [46] - Cash management strategies have yielded a return of 9.44 million yuan during the reporting period, ensuring liquidity and safety of funds [46] - The company has actively engaged in investor communication, hosting multiple events to enhance transparency and information dissemination [49][50]

Core Points - The company has decided to cancel its supervisory board and will allow the audit committee of the board to exercise the functions of the supervisory board as per the new Company Law [2][3] - The company will revise its Articles of Association to reflect this change and will also update related governance systems to enhance operational standards [5][6] - The changes will be submitted for approval at the upcoming shareholders' meeting, and the management team will be authorized to handle the necessary registration procedures [5][6] Company Overview - The company is named Nanjing Weisi Medical Technology Co., Ltd., with the stock code 688580 and the announcement number 2025-032 [2] - The company emphasizes the importance of maintaining compliance with legal regulations and protecting the interests of shareholders during the transition [3][4]

Group 1 - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [2] - The company held its 25th meeting of the 7th Board of Directors on August 27, 2025, via communication voting, with all 8 directors present [6][9] - The Board approved the 2025 semi-annual report and its summary, confirming that the report's preparation complies with legal regulations and accurately reflects the company's situation [7][8] Group 2 - The company plans to provide guarantees for its subsidiary, Anhui Xuhe New Energy Technology Co., Ltd., to ensure stable cooperation with suppliers, with a guarantee amount exceeding 100% of the company's latest audited net assets [24][25] - The total amount of guarantees provided by the company and its subsidiaries is 3 billion, which is 9,220.31% of the company's audited net assets for 2024 [33] - The independent directors unanimously agreed that the guarantee for the subsidiary aligns with legal regulations and will not adversely affect the company or its shareholders [33]

Core Viewpoint - The company has undergone significant changes in its shareholder structure and management, while also planning to continue its financial support to subsidiaries and maintain its auditing arrangements for the upcoming year [7][11][54]. Group 1: Company Overview - The company is named Shenzhen Lihe Science and Technology Co., Ltd. and is listed under the stock code 002243 [1]. - The company has not changed its controlling shareholder or actual controller during the reporting period [4][5]. Group 2: Financial and Operational Updates - The company plans not to distribute cash dividends or issue bonus shares for the reporting period [2]. - The company issued a total of RMB 700 million in medium-term notes with an interest rate of 2.18% [9]. - The company approved a financial assistance plan to provide up to RMB 640 million to its wholly-owned subsidiary Guangzhou Lihe Science and Technology Center [22]. Group 3: Shareholder Structure Changes - The company announced a change in the upper shareholder structure of its controlling shareholder, Shenzhen Qingyan Investment Holdings Co., Ltd., which was transferred to the Shenzhen Municipal Government State-owned Assets Supervision and Administration Commission [7][10]. - The transfer of 100% equity of the controlling shareholder was completed without affecting the company's governance structure [11]. Group 4: Management Changes - The company appointed Xu Anbi as the new general manager after the resignation of He Zhen, who will continue as chairman [8][12]. - The company also elected Yang Gaoyu as an independent director following the resignation of Zhang Hanbin [12]. Group 5: Audit and Compliance - The company has proposed to continue using the auditing services of Deloitte Touche Tohmatsu Certified Public Accountants for the year 2025, with an expected audit fee of RMB 1.7 million [54][55]. - The audit committee and supervisory board have reviewed and approved the decision to retain the auditing firm, ensuring compliance with relevant regulations [66].

Core Points - The company, Anhui Quanchai Power Co., Ltd., held its ninth board meeting on August 27, 2025, to discuss the 2025 semi-annual report and other significant matters [7][8] - The board approved the semi-annual report and a special report on the use of raised funds, both of which will be disclosed on the Shanghai Stock Exchange website [9][10] - The company plans to cancel its supervisory board and amend its articles of association, transferring the supervisory responsibilities to the audit committee [20][21] Company Overview - Anhui Quanchai Power Co., Ltd. is identified by stock code 600218 and is publicly listed [6] - The company has confirmed that all board members attended the meeting, ensuring compliance with legal and regulatory requirements [2][7] Financial Data - The semi-annual report is unaudited, and the company has decided not to distribute profits or increase capital reserves for the first half of 2025 [3][4] Important Resolutions - The board approved several resolutions, including the cancellation of the supervisory board and amendments to the company's governance documents [11][20] - A temporary shareholders' meeting is scheduled for September 19, 2025, to further discuss and approve the proposed changes [23][24] Meeting Details - The upcoming shareholders' meeting will utilize both on-site and online voting methods, with specific times and procedures outlined for participation [25][32] - Shareholders must register to attend the meeting, with detailed instructions provided for both individual and institutional investors [39][40]